Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The French generics market had total revenues of $4.2 billion in 2022, representing a compound annual growth rate (CAGR) of 2.8% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 1.3% between 2017 and 2022, to reach a total of 86.1% in 2022.
- Factors such as accelerating healthcare costs, growing consumer price inflation, rising expiration of patents for branded medicines, and growing first generic drug approvals are driving the generics market. According to in-house research, in 2022, the consumer price inflation-health in France reached 0.8%.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts
Reasons to Buy
- What was the size of the France generics market by value in 2022?
- What will be the size of the France generics market in 2027?
- What factors are affecting the strength of competition in the France generics market?
- How has the market performed over the last five years?
- What are the main segments that make up France's generics market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teva Pharmaceutical Industries Limited
- Pfizer Inc.
- Sanofi SA
- Les Laboratoires Servier
